These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 32234499)

  • 1. Hsa_circ_0011290 regulates proliferation, apoptosis and glycolytic phenotype in papillary thyroid cancer via miR-1252/ FSTL1 signal pathway.
    Hu Z; Zhao P; Zhang K; Zang L; Liao H; Ma W
    Arch Biochem Biophys; 2020 May; 685():108353. PubMed ID: 32234499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circ_0002111/miR-134-5p/FSTL1 signal axis regulates tumor progression and glycolytic metabolism in papillary thyroid carcinoma cells.
    Zhang H; Jiang J; He X; Zhou Q
    J Endocrinol Invest; 2023 Apr; 46(4):713-725. PubMed ID: 36227499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hsa_circ_0058129 regulates papillary thyroid cancer development via miR-873-5p/follistatin-like 1 axis.
    Tan X; Zhao J; Lou J; Zheng W; Wang P
    J Clin Lab Anal; 2022 May; 36(5):e24401. PubMed ID: 35373391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circular RNA circ_HECTD1 regulates cell injury after cerebral infarction by miR-27a-3p/FSTL1 axis.
    Zhang Z; He J; Wang B
    Cell Cycle; 2021 May; 20(9):914-926. PubMed ID: 33843447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circular RNA hsa_circ_0001666 sponges miR‑330‑5p, miR‑193a‑5p and miR‑326, and promotes papillary thyroid carcinoma progression via upregulation of ETV4.
    Qi Y; He J; Zhang Y; Wang L; Yu Y; Yao B; Tian Z
    Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33760216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hsa_circ_CSPP1/MiR-361-5p/ITGB1 Regulates Proliferation and Migration of Cervical Cancer (CC) by Modulating the PI3K-Akt Signaling Pathway.
    Yang W; Xie T
    Reprod Sci; 2020 Jan; 27(1):132-144. PubMed ID: 32046405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hsa_circ_0010023 promotes the development of papillary thyroid carcinoma by sponging miR-1250-5p.
    Wang L; Wang Y; Wu W; Qian L; Jin P
    Endocrine; 2024 Nov; 86(2):744-752. PubMed ID: 38914746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silencing circRNA protein kinase C iota (circ-PRKCI) suppresses cell progression and glycolysis of human papillary thyroid cancer through circ-PRKCI/miR-335/E2F3 ceRNA axis.
    Liu Y; Chen G; Wang B; Wu H; Zhang Y; Ye H
    Endocr J; 2021 Jun; 68(6):713-727. PubMed ID: 33716239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hsa_circ_0092355 Accelerates Papillary Thyroid Cancer Progression by Regulating the miR-543/PDE5A Pathway.
    Sun Z; Zhang M; Ye Y; Yang L
    Horm Metab Res; 2024 May; 56(5):381-391. PubMed ID: 38286403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulated hsa_circ_0004458 Contributes to Progression of Papillary Thyroid Carcinoma by Inhibition of miR-885-5p and Activation of RAC1.
    Jin X; Wang Z; Pang W; Zhou J; Liang Y; Yang J; Yang L; Zhang Q
    Med Sci Monit; 2018 Aug; 24():5488-5500. PubMed ID: 30086127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circ_0079558 promotes papillary thyroid cancer progression by binding to miR-26b-5p to activate MET/AKT signaling.
    Zheng H; Fu Q; Ma K; Shi S; Fu Y
    Endocr J; 2021 Nov; 68(11):1247-1266. PubMed ID: 34565758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circular RNA circ_0008274 enhances the malignant progression of papillary thyroid carcinoma via modulating solute carrier family 7 member 11 by sponging miR-154-3p.
    Ma J; Kan Z
    Endocr J; 2021 May; 68(5):543-552. PubMed ID: 33473055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hsa_circ_0058124 promotes papillary thyroid cancer tumorigenesis and invasiveness through the NOTCH3/GATAD2A axis.
    Yao Y; Chen X; Yang H; Chen W; Qian Y; Yan Z; Liao T; Yao W; Wu W; Yu T; Chen Y; Zhang Y
    J Exp Clin Cancer Res; 2019 Jul; 38(1):318. PubMed ID: 31324198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knockdown of circPUM1 impedes cell growth, metastasis and glycolysis of papillary thyroid cancer via enhancing MAPK1 expression by serving as the sponge of miR-21-5p.
    Li Y; Qin J; He Z; Cui G; Zhang K; Wu B
    Genes Genomics; 2021 Feb; 43(2):141-150. PubMed ID: 33481227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hsa_circ_0056558 regulates cyclin-dependent kinase 6 by sponging microRNA-1290 to suppress the proliferation and differentiation in ankylosing spondylitis.
    Li X; Zhou W; Li Z; Guan F
    Autoimmunity; 2021 Mar; 54(2):114-128. PubMed ID: 33685301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circ_PSD3 promotes the progression of papillary thyroid carcinoma via the miR-637/HEMGN axis.
    Li Z; Huang X; Liu A; Xu J; Lai J; Guan H; Ma J
    Life Sci; 2021 Jan; 264():118622. PubMed ID: 33203523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circ_TLK1 knockdown alleviates oxygen-glucose deprivation/reoxygenation-induced PC12 cell injury by regulating microRNA-136-5p/follistatin like-1 axis.
    Zhang Z; He J; Wang B
    Eur J Neurosci; 2022 Aug; 56(4):4304-4316. PubMed ID: 35766911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circ-WDR27 regulates mycobacterial vitality and secretion of inflammatory cytokines in Mycobacterium tuberculosis-infected macrophages via the miR-370-3p/FSTL1 signal network.
    Zhang Y; Luo D; Tang MI; Jiang DI; Yi H
    J Biosci; 2022; 47():. PubMed ID: 36210730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hsa_circ_0039411 promotes tumorigenesis and progression of papillary thyroid cancer by miR-1179/ABCA9 and miR-1205/MTA1 signaling pathways.
    Yang Y; Ding L; Li Y; Xuan C
    J Cell Physiol; 2020 Feb; 235(2):1321-1329. PubMed ID: 31270819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. circRPS28 (hsa_circ_0049055) is a novel contributor for papillary thyroid carcinoma by regulating cell growth and motility via functioning as ceRNA for miR-345-5p to regulate frizzled family receptor 8 (FZD8).
    Mao Y; Huo Y; Li J; Zhao Y; Wang Y; Sun L; Kang Z
    Endocr J; 2021 Nov; 68(11):1267-1281. PubMed ID: 34108309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.